Initial Results of Tests Using GSR Biofeedback as a New Neurorehabilitation Technology Complementing Pharmacological Treatment of Patients with Schizophrenia.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2021
Historique:
received: 16 01 2021
revised: 22 05 2021
accepted: 04 06 2021
entrez: 5 7 2021
pubmed: 6 7 2021
medline: 26 10 2021
Statut: epublish

Résumé

Galvanic skin response (GSR) Biofeedback uses training to reduce tension and anxiety and improve concentration and self-regulation. The study was aimed to evaluate this method as a form of rehabilitation and quantify the outcomes achieved by patients undergoing training using this technique. Six schizophrenic patients were enrolled in the study and underwent training based on the relaxation training module (CENTER), concentration training module (BALANCE), and self-regulation training module (INSECTS). Training sessions were held twice a week for 6 weeks. From the total group of subjects involved in the study, two patients had a statistically significant increase in measured values after the CENTER exercise, indicating that relaxation was achieved. Four patients showed a statistically significant decrease in measured values after the BALANCE exercise, which was reflective of an improvement in concentration. Three patients had a statistically significant decrease in measured values after the INSECTS exercise, which indicated an improvement in self-regulation. GSR Biofeedback may be used to complement the pharmacological treatment of patients diagnosed with schizophrenia.

Identifiants

pubmed: 34222472
doi: 10.1155/2021/5552937
pmc: PMC8213473
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5552937

Informations de copyright

Copyright © 2021 Renata Markiewicz and Beata Dobrowolska.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest.

Références

Arch Gen Psychiatry. 1999 Aug;56(8):749-54
pubmed: 10435610
Psychophysiology. 1999 Sep;36(5):543-51
pubmed: 10442022
Encephale. 2017 Apr;43(2):135-145
pubmed: 28041692
Synapse. 1990;6(3):271-8
pubmed: 2237784
Psychiatry Res. 2001 Nov 1;104(2):119-31
pubmed: 11711166
J Abnorm Psychol. 2005 Nov;114(4):494-504
pubmed: 16351373
Neurophysiol Clin. 2020 Feb;50(1):1-3
pubmed: 32007382
Appl Psychophysiol Biofeedback. 2016 Mar;41(1):61-9
pubmed: 26346569
Encephale. 2019 Jun;45(3):245-255
pubmed: 30885442
Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S78-85
pubmed: 11748791
J Psychiatr Res. 2013 Dec;47(12):1925-31
pubmed: 24050778
Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2:S132-6
pubmed: 20936298
Psychiatry Res. 2012 Dec 30;200(2-3):294-305
pubmed: 22560057
Acta Neuropsychiatr. 2000 Dec;12(4):177-82
pubmed: 26975432
Trends Cogn Sci. 2013 Jun;17(6):295-302
pubmed: 23664452
Arch Gen Psychiatry. 2001 Jan;58(1):24-32
pubmed: 11146755
Arch Gen Psychiatry. 1983 May;40(5):557-65
pubmed: 6838333
Schizophr Res. 2000 May 25;43(1):47-55
pubmed: 10828414
Biol Psychiatry. 1985 Feb;20(2):158-62
pubmed: 3970996
Arch Gen Psychiatry. 1994 Feb;51(2):124-31
pubmed: 7905258
Appl Psychophysiol Biofeedback. 2008 Sep;33(3):141-8
pubmed: 18509756
Neuroimage. 2013 Jul 15;75:176
pubmed: 23466940
Schizophr Res. 2002 Jan 15;53(3):249-61
pubmed: 11738538
Psychiatr Pol. 2019 Dec 31;53(6):1261-1273
pubmed: 32017816
J Nerv Ment Dis. 1982 Feb;170(2):91-101
pubmed: 7057175
Psychophysiology. 2005 Jul;42(4):483-92
pubmed: 16008777
J Affect Disord. 2020 Apr 1;266:235-242
pubmed: 32056883
Hist Psychiatry. 1992 Dec;3(12):499-29
pubmed: 11612918
Can J Psychiatry. 1999 Sep;44(7):697-700
pubmed: 10500872
J Affect Disord. 2010 Jun;123(1-3):138-49
pubmed: 19819558
Neuron. 2005 Sep 15;47(6):783-6
pubmed: 16157273
Biol Psychol. 1982 May-Jun;14(3-4):155-211
pubmed: 6127121
Psychol Med. 1976 May;6(2):245-9
pubmed: 826921
CNS Spectr. 2006 Jun;11(6):455-61
pubmed: 16816777
Encephale. 2008 Dec;34(6):557-62
pubmed: 19081451
Schizophr Res. 1997 Apr 11;24(3):289-98
pubmed: 9134589
Neuroimage. 2013 Nov 1;81:422-430
pubmed: 23668967
Psychiatr Pol. 2018 Apr 30;52(2):217-226
pubmed: 29975362
Neuroimage Clin. 2014 Jul 10;5:245-55
pubmed: 25161891
Schizophr Bull. 1997;23(1):19-28
pubmed: 9050110
Bosn J Basic Med Sci. 2019 Aug 20;19(3):213-220
pubmed: 30465705

Auteurs

Renata Markiewicz (R)

Psychiatric Nursing Department, Faculty of Health Sciences, Medical University of Lublin, Poland.

Beata Dobrowolska (B)

Department of Management in Nursing, Faculty of Health Sciences, Medical University of Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH